A citation-based method for searching scientific literature

Souzan Sanati. Am J Pathol 2019
Times Cited: 12







List of co-cited articles
60 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Preliminary results of centralized HER2 testing in ductal carcinoma in situ (DCIS): NSABP B-43.
Kalliopi P Siziopikou, Stewart J Anderson, Melody A Cobleigh, Thomas B Julian, Douglas W Arthur, Ping Zheng, Eleftherios P Mamounas, Eduardo R Pajon, Robert J Behrens, Janice F Eakle,[...]. Breast Cancer Res Treat 2013
41
25


Breast cancer precursors revisited: molecular features and progression pathways.
Maria A Lopez-Garcia, Felipe C Geyer, Magali Lacroix-Triki, Caterina Marchió, Jorge S Reis-Filho. Histopathology 2010
191
25

Feasibility of a prospective, randomised, open-label, international multicentre, phase III, non-inferiority trial to assess the safety of active surveillance for low risk ductal carcinoma in situ - The LORD study.
Lotte E Elshof, Konstantinos Tryfonidis, Leen Slaets, A Elise van Leeuwen-Stok, Victoria P Skinner, Nicolas Dif, Ruud M Pijnappel, Nina Bijker, Emiel J Th Rutgers, Jelle Wesseling. Eur J Cancer 2015
192
25

Classification of ductal carcinoma in situ by gene expression profiling.
Juliane Hannemann, Arno Velds, Johannes B G Halfwerk, Bas Kreike, Johannes L Peterse, Marc J van de Vijver. Breast Cancer Res 2006
117
25

Significant inter- and intra-laboratory variation in grading of ductal carcinoma in situ of the breast: a nationwide study of 4901 patients in the Netherlands.
Carmen van Dooijeweert, Paul J van Diest, Stefan M Willems, Chantal C H J Kuijpers, Lucy I H Overbeek, Ivette A G Deckers. Breast Cancer Res Treat 2019
20
25

Nomogram for predicting the risk of local recurrence after breast-conserving surgery for ductal carcinoma in situ.
Udo Rudloff, Lindsay M Jacks, Jessica I Goldberg, Christine A Wynveen, Edi Brogi, Sujata Patil, Kimberly J Van Zee. J Clin Oncol 2010
204
25

A multigene expression assay to predict local recurrence risk for ductal carcinoma in situ of the breast.
Lawrence J Solin, Robert Gray, Frederick L Baehner, Steven M Butler, Lorie L Hughes, Carl Yoshizawa, Diana B Cherbavaz, Steven Shak, David L Page, George W Sledge,[...]. J Natl Cancer Inst 2013
322
25

Molecular Evaluation of Breast Ductal Carcinoma in Situ with Oncotype DX DCIS.
Sharon Nofech-Mozes, Wedad Hanna, Eileen Rakovitch. Am J Pathol 2019
16
25

Impact of microinvasion on breast cancer mortality in women with ductal carcinoma in situ.
Victoria Sopik, Ping Sun, Steven A Narod. Breast Cancer Res Treat 2018
39
16

Confusion Over Differences in Registration and Randomization Criteria for the LORIS (Low-Risk DCIS) Trial.
Daniel Rea, Adele Francis, Matthew Wallis, Jeremy Thomas, John Bartlett, Sarah Bowden, David Dodwell, Lesley Fallowfield, Claire Gaunt, Andrew Hanby,[...]. Ann Surg Oncol 2017
5
40

Interobserver reproducibility of the Lagios nuclear grading system for ductal carcinoma in situ.
N Sneige, M D Lagios, R Schwarting, W Colburn, E Atkinson, D Weber, A Sahin, B Kemp, A Hoque, S Risin,[...]. Hum Pathol 1999
50
16

Current trials to reduce surgical intervention in ductal carcinoma in situ of the breast: Critical review.
M Toss, I Miligy, A M Thompson, H Khout, A R Green, I O Ellis, E A Rakha. Breast 2017
21
16

Extent of ductal carcinoma in situ according to breast cancer subtypes: a population-based cohort study.
Shusma C Doebar, Esther C van den Broek, Linetta B Koppert, Agnes Jager, Margreet H A Baaijens, Inge-Marie A M Obdeijn, Carolien H M van Deurzen. Breast Cancer Res Treat 2016
31
16

Current treatment trends and the need for better predictive tools in the management of ductal carcinoma in situ of the breast.
Carlos Martínez-Pérez, Arran K Turnbull, Gregory E Ekatah, Laura M Arthur, Andrew H Sims, Jeremy S Thomas, J Michael Dixon. Cancer Treat Rev 2017
23
16

Postoperative tamoxifen for ductal carcinoma in situ.
Helen Staley, Iain McCallum, Julie Bruce. Cochrane Database Syst Rev 2012
34
16

Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS.
Irene L Wapnir, James J Dignam, Bernard Fisher, Eleftherios P Mamounas, Stewart J Anderson, Thomas B Julian, Stephanie R Land, Richard G Margolese, Sandra M Swain, Joseph P Costantino,[...]. J Natl Cancer Inst 2011
449
16

Dichotomous histopathological assessment of ductal carcinoma in situ of the breast results in substantial interobserver concordance.
Mieke Van Bockstal, Marcella Baldewijns, Cécile Colpaert, Hélène Dano, Giuseppe Floris, Christine Galant, Kathleen Lambein, Dieter Peeters, Sofie Van Renterghem, Anne-Sophie Van Rompuy,[...]. Histopathology 2018
19
16

Risk factors for non-invasive and invasive local recurrence in patients with ductal carcinoma in situ.
Laura C Collins, Ninah Achacoso, Reina Haque, Larissa Nekhlyudov, Suzanne W Fletcher, Charles P Quesenberry, Stuart J Schnitt, Laurel A Habel. Breast Cancer Res Treat 2013
40
16

Biomarker expression and risk of subsequent tumors after initial ductal carcinoma in situ diagnosis.
Karla Kerlikowske, Annette M Molinaro, Mona L Gauthier, Hal K Berman, Fred Waldman, James Bennington, Henry Sanchez, Cynthia Jimenez, Kim Stewart, Karen Chew,[...]. J Natl Cancer Inst 2010
234
16

Ductal carcinoma in situ at core-needle biopsy: meta-analysis of underestimation and predictors of invasive breast cancer.
Meagan E Brennan, Robin M Turner, Stefano Ciatto, M Luke Marinovich, James R French, Petra Macaskill, Nehmat Houssami. Radiology 2011
227
16

The COMET (Comparison of Operative versus Monitoring and Endocrine Therapy) trial: a phase III randomised controlled clinical trial for low-risk ductal carcinoma in situ (DCIS).
E Shelley Hwang, Terry Hyslop, Thomas Lynch, Elizabeth Frank, Donna Pinto, Desiree Basila, Deborah Collyar, Antonia Bennett, Celia Kaplan, Shoshana Rosenberg,[...]. BMJ Open 2019
104
16


The diagnostic challenge of low-grade ductal carcinoma in situ.
Tracy Onega, Donald L Weaver, Paul D Frederick, Kimberly H Allison, Anna N A Tosteson, Patricia A Carney, Berta M Geller, Gary M Longton, Heidi D Nelson, Natalia V Oster,[...]. Eur J Cancer 2017
22
16

Post-operative radiotherapy for ductal carcinoma in situ of the breast.
Annabel Goodwin, Sharon Parker, Davina Ghersi, Nicholas Wilcken. Cochrane Database Syst Rev 2013
40
16

Comparison of HER2 amplification status among breast cancer subgroups offers new insights in pathways of breast cancer progression.
Kathleen Lambein, Mieke Van Bockstal, Lies Vandemaele, Rudy Van den Broecke, Veronique Cocquyt, Sofie Geenen, Hannelore Denys, Louis Libbrecht. Virchows Arch 2017
9
22

Risk of subsequent in situ and invasive breast cancer in human epidermal growth factor receptor 2-positive ductal carcinoma in situ.
G Curigliano, D Disalvatore, A Esposito, G Pruneri, M Lazzeroni, A Guerrieri-Gonzaga, A Luini, R Orecchia, A Goldhirsch, N Rotmensz,[...]. Ann Oncol 2015
34
16

A Validated Nomogram to Predict Upstaging of Ductal Carcinoma in Situ to Invasive Disease.
James W Jakub, Brittany L Murphy, Alexandra B Gonzalez, Amy L Conners, Tara L Henrichsen, Santo Maimone, Michael G Keeney, Sarah A McLaughlin, Barbara A Pockaj, Beiyun Chen,[...]. Ann Surg Oncol 2017
27
16

Molecular grading of ductal carcinoma in situ of the breast.
Rosemary L Balleine, Lucy R Webster, Sean Davis, Elizabeth L Salisbury, Juan P Palazzo, Gordon F Schwartz, Dennis B Cornfield, Robert L Walker, Karen Byth, Christine L Clarke,[...]. Clin Cancer Res 2008
44
16

Do LORIS Trial Eligibility Criteria Identify a Ductal Carcinoma In Situ Patient Population at Low Risk of Upgrade to Invasive Carcinoma?
Melissa Pilewskie, Michelle Stempel, Hope Rosenfeld, Anne Eaton, Kimberly J Van Zee, Monica Morrow. Ann Surg Oncol 2016
54
16

A Comparison of Tumor Biology in Primary Ductal Carcinoma In Situ Recurring as Invasive Carcinoma versus a New In Situ.
Wenjing Zhou, Christine Johansson, Karin Jirström, Anita Ringberg, Carl Blomqvist, Rose-Marie Amini, Marie-Louise Fjallskog, Fredrik Wärnberg. Int J Breast Cancer 2013
15
16

Refined estimates of local recurrence risks by DCIS score adjusting for clinicopathological features: a combined analysis of ECOG-ACRIN E5194 and Ontario DCIS cohort studies.
E Rakovitch, R Gray, F L Baehner, R Sutradhar, M Crager, S Gu, S Nofech-Mozes, S S Badve, W Hanna, L L Hughes,[...]. Breast Cancer Res Treat 2018
28
16

Stromal characteristics are adequate prognosticators for recurrence risk in ductal carcinoma in situ of the breast.
Mieke Van Bockstal, Kathleen Lambein, Ann Smeets, Laurence Slembrouck, Patrick Neven, Ines Nevelsteen, Caroline Weltens, Erik Van Limbergen, Marie-Rose Christiaens, Chantal Van Ongeval,[...]. Eur J Surg Oncol 2019
10
20

Risk factors for the development of invasive cancer in unresected ductal carcinoma in situ.
Anthony J Maxwell, Karen Clements, Bridget Hilton, David J Dodwell, Andrew Evans, Olive Kearins, Sarah E Pinder, Jeremy Thomas, Matthew G Wallis, Alastair M Thompson. Eur J Surg Oncol 2018
43
16

Copy number analysis of ductal carcinoma in situ with and without recurrence.
Kylie L Gorringe, Sally M Hunter, Jia-Min Pang, Ken Opeskin, Prue Hill, Simone M Rowley, David Y H Choong, Ella R Thompson, Alexander Dobrovic, Stephen B Fox,[...]. Mod Pathol 2015
24
16

Prevalence of incidental breast cancer and precursor lesions in autopsy studies: a systematic review and meta-analysis.
Elizabeth T Thomas, Chris Del Mar, Paul Glasziou, Gordon Wright, Alexandra Barratt, Katy J L Bell. BMC Cancer 2017
22
16

Tumor-infiltrating lymphocytes and ductal carcinoma in situ of the breast: friends or foes?
Marie Colombe Agahozo, Dora Hammerl, Reno Debets, Marleen Kok, Carolien H M van Deurzen. Mod Pathol 2018
20
16

Surgical Upstaging Rates for Vacuum Assisted Biopsy Proven DCIS: Implications for Active Surveillance Trials.
Lars J Grimm, Marc D Ryser, Ann H Partridge, Alastair M Thompson, Jeremy S Thomas, Jelle Wesseling, E Shelley Hwang. Ann Surg Oncol 2017
48
16

Outcome of patients with ductal carcinoma in situ untreated after diagnostic biopsy: results from the Nurses' Health Study.
Laura C Collins, Rulla M Tamimi, Heather J Baer, James L Connolly, Graham A Colditz, Stuart J Schnitt. Cancer 2005
175
16

Adjuvant tamoxifen reduces subsequent breast cancer in women with estrogen receptor-positive ductal carcinoma in situ: a study based on NSABP protocol B-24.
D Craig Allred, Stewart J Anderson, Soonmyung Paik, D Lawrence Wickerham, Iris D Nagtegaal, Sandra M Swain, Elefetherios P Mamounas, Thomas B Julian, Charles E Geyer, Joseph P Costantino,[...]. J Clin Oncol 2012
197
16


Gene amplification in ductal carcinoma in situ of the breast.
L Burkhardt, T J Grob, I Hermann, E Burandt, M Choschzick, F Jänicke, V Müller, C Bokemeyer, R Simon, G Sauter,[...]. Breast Cancer Res Treat 2010
53
16


Progression-specific genes identified in microdissected formalin-fixed and paraffin-embedded tissue containing matched ductal carcinoma in situ and invasive ductal breast cancers.
Silke Schultz, Harald Bartsch, Karl Sotlar, Karina Petat-Dutter, Michael Bonin, Steffen Kahlert, Nadia Harbeck, Ulrich Vogel, Harald Seeger, Tanja Fehm,[...]. BMC Med Genomics 2018
8
25

Ductal Carcinoma in Situ Biomarkers in a Precision Medicine Era: Current and Future Molecular-Based Testing.
Kevin Shee, Kristen E Muller, Jonathan Marotti, Todd W Miller, Wendy A Wells, Gregory J Tsongalis. Am J Pathol 2019
8
25

Paradigm Shift toward Reducing Overtreatment of Ductal Carcinoma In Situ of Breast.
Yasuaki Sagara, Wong Julia, Mehra Golshan, Masakazu Toi. Front Oncol 2017
18
16

Local excision alone without irradiation for ductal carcinoma in situ of the breast: a trial of the Eastern Cooperative Oncology Group.
Lorie L Hughes, Molin Wang, David L Page, Robert Gray, Lawrence J Solin, Nancy E Davidson, Mary Ann Lowen, James N Ingle, Abram Recht, William C Wood. J Clin Oncol 2009
215
16

Multiclonal Invasion in Breast Tumors Identified by Topographic Single Cell Sequencing.
Anna K Casasent, Aislyn Schalck, Ruli Gao, Emi Sei, Annalyssa Long, William Pangburn, Tod Casasent, Funda Meric-Bernstam, Mary E Edgerton, Nicholas E Navin. Cell 2018
188
16


PI3K pathway activation in high-grade ductal carcinoma in situ--implications for progression to invasive breast carcinoma.
Rita A Sakr, Britta Weigelt, Sarat Chandarlapaty, Victor P Andrade, Elena Guerini-Rocco, Dilip Giri, Charlotte K Y Ng, Catherine F Cowell, Neal Rosen, Jorge S Reis-Filho,[...]. Clin Cancer Res 2014
34
16


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.